In study group, 2-3 mg/kg propofol, 1mcg/kg fentanyl and 0.15 mg/kg rocuronium bromide will be administered during lma insertion in cystoscopy procedure.

In control group, 2-3 mg/kg propofol, 1 mcg/kg fentanyl and saline(no rocuronium) will be administered during lma insertion in cystoscopy procedure.

Anesthesia

Rocuronium Bromide

Saline Solution

Fentanyl

Propofol

patients will treated with this surgical procedure

cystoscopy

Erciyes University

Effects of Low Dose Neuromuscular Blocker Usage on Laryngeal Mask Application

Comparison of Effects of Low Dose Neuromuscular Blocker Added to Propofol Fentanyl Combination During Lma Procedures in Cystoscopy Patients

The quality of LMA placement with or without neuromusculer drug.

after the surgery soar throat will be evaluated

Ayse Ulgey

associate professor

TC Erciyes University

before 15 minute anesthesia induction Chlorhexidine-benzidamine spray will be administrated to oropharynx

before 15 minute normal salin will be administrated to oropharynx

Effects of Topical Chlorhexidine and Benzidine Spray

before induction will be used for oropharynx

Chlorobenzene Liquid

Ministry of Health Diskapi Yıldırım Beyazıt Training and Research Hospital

To Evaluate the Effect of Chlorhexidine-benzidamine Administration

To Evaluate the Effect of Chlorhexidine-benzidamine Administration Prior to the Use of the Laryngeal Mask

was assessed because of coughing, tooth clenching, desaturation, and lack of laryngeal spasm

sore throat, ear pain, swallowing difficulty, nausea and vomiting

systolic, diastolic and mean blood pressure will record before LMA and post LMA used at first minute.

Heart rate will record before LMA insertion and post LMA used at first minute.

Savas Altinsoy

Diskapi Yildirim Beyazit Education and Research Hospital anestehesia and reanimation

Diskapi Yildirim Beyazit Education and Research Hospital

Intravenous (0.02mg/kg Midazolam and 2 microgram/kg Fentanyl) and oxygen via a face mask will be administered. Two minutes later, general anesthesia will be induced using 2 mg/kg intravenous Propofol mixed with 25 mg Lidocaine Injected over 30 seconds, Mask ventilation commence and continue for at least 30 seconds until conditions are suitable for PLMA insertion

Intravenous (0.02mg/kg Midazolam and 2 microgram/kg Fentanyl) and oxygen via a face mask will be administered. Two minutes later, general anesthesia will be induced using 2 mg/kg intravenous Propofol mixed with 25 mg Lidocaine Injected over 30 seconds, Mask ventilation commence and continue for at least 30 seconds until conditions are suitable for AmbuAuraGain Laryngeal Mask Airway insertion

Laryngeal Masks

ProSeal Laryngeal Mask Airway was used as the supraglottic device

ProSeal Laryngeal Mask Airway

AmbuAuraGain Laryngeal Mask Airway was used as the supraglottic device

AmbuAuraGain Laryngeal Mask Airway

Tata Main Hospital

Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway

Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway in Spontaneously Breathing Patients Undergoing Elective Surgery Under General Anaesthesia

A failed insertion attempt is defined as when removal of the device needed from the mouth.

Time taken for insertion from picking up the LMA till confirmation of effective ventilation

The number of insertion attempts or failed attempt to achieve effective ventilation. A failed insertion attempt is defined as when removal of the device needed from the mouth. Three attempts allowed before insertion will be considered a failure.

Intracuff and the oropharyngeal leak pressures after ensuring effective placement. These pressures will be determined by closing the expiratory valve of the circle system at a fresh gas flow of 3 l/min, note the airway pressure (maximum allowed: 40 cm H2O) at which equilibrium was reached.

The time taken for correct placement will be recorded, from Picking up the orogastric tube till confirmation of its placement.

Dr.Deb Sanjay Nag

Consultant

Prospective randomized single blinded parallel group controlled study

Sequentially numbered, sealed, opaque envelopes: Participant and Outcome Assessor Blinded

Insertion of the supraglottic device and evaluation of its clinical performance

Laparoscopy

Airway Management

Supraglottic Airway Devices

Evaluation of clinical performance in terms of Insertion, ventilation, position and complications

Ambu AuraGain evaluation

LMA Supreme evaluation

Gynecologic laparoscopic surgery in the trendelemburg position

Laparoscopic surgery

Ambulatory Surgery, Hospital Clinic de Barcelona

Ambu AuraGain vs LMA Supreme in Laparoscopic Surgery

Comparison of the Ambu AuraGain vs. LMA Supreme in Paralysed Patients Undergoing Gynecologic Laparoscopic Surgery in the Trendelemburg Position

Maximum airway pressure that the device can achieve without oropharyngeal leak of gas.

number of manoeuvres/corrections required

Assessment of alignment with the glottic inlet as: complete view of the vocal cords (I), epiglottis visible inside, but not causing any obstruction (II), epiglottis visible and causing obstruction (III) or glottis not identified (IV)

Ease of passage of a gastric tube as: easy, difficult or impossible

number of patients with adverse events: Airway obstruction, desaturation, Aspiration, oropharyngeal trauma, sore throat

hiccup/hypoxia

Effects of Low Dose Neuromuscular Blocker Usage on Laryngeal Mask Application

To Evaluate the Effect of Chlorhexidine-benzidamine Administration

Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway

Ambu AuraGain vs LMA Supreme in Laparoscopic Surgery

科學支持的最完整的草藥數據庫